Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1988]

Subcutaneous versus intravenous daratumumab administration in patients with...

Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain

$Subcutaneous versus intravenous daratumumab administration in patients with relapsed or refractory multiple myeloma ( Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain )$

Novel adoptive cell therapies for acute lymphoblastic leukaemia

Prof Rupert Handgretinger, Director and Chair, Children’s University Hospital...

Novel adoptive cell therapies for acute lymphoblastic leukaemia ( Prof Rupert Handgretinger, Director and Chair, Children’s University Hospital and Department of Haematology/Oncology, Tübingen, Germany )

Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse

Prof David Marks - University Hospital Bristol, Bristol, UK

Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse ( Prof David Marks - University Hospital Bristol, Bristol, UK )

CNS involvement and prophylaxis in acute lymphoblastic leukaemia

Dr Mark Litzow - Mayo Clinic, Rochester, USA

CNS involvement and prophylaxis in acute lymphoblastic leukaemia ( Dr Mark Litzow - Mayo Clinic, Rochester, USA )

Indications for allogeneic haematopoietic stem cell transplantation in adult...

Dr Mark Litzow - Mayo Clinic, Rochester, USA

Indications for allogeneic haematopoietic stem cell transplantation in adult acute lymphoblastic leukaemia ( Dr Mark Litzow - Mayo Clinic, Rochester, USA )

Metabolic vulnerability in NOTCH-driven T cell acute lymphoblastic leukaemia

Dr Etienne De Braekeleer - Wellcome Sanger Institute, Cambridge, UK

Metabolic vulnerability in NOTCH-driven T cell acute lymphoblastic leukaemia ( Dr Etienne De Braekeleer - Wellcome Sanger Institute, Cambridge, UK )

MLL-rearranged acute lymphoblastic leukaemia

Dr Pablo Menéndez - Josep Carreras Leukemia Research Institute, Barcelona, Spain

MLL-rearranged acute lymphoblastic leukaemia ( Dr Pablo Menéndez - Josep Carreras Leukemia Research Institute, Barcelona, Spain )

Updates on bispecific T cell engagers (BiTEs) for the treatment of acute...

Prof Max Topp - University of Würzburg, Würzburg, Germany

Updates on bispecific T cell engagers (BiTEs) for the treatment of acute lymphoblastic leukaemia ( Prof Max Topp - University of Würzburg, Würzburg, Germany )

MRD management in adults with acute lymphoblastic leukaemia

Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy

MRD management in adults with acute lymphoblastic leukaemia ( Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy )

Using CAR T cells for the treatment of acute lymphoblastic leukaemia

Prof Claudia Rossig - Universität Münster, Münster, Germany

Using CAR T cells for the treatment of acute lymphoblastic leukaemia ( Prof Claudia Rossig - Universität Münster, Münster, Germany )

Optimal use of tyrosine kinase inhibitors as a treatment for Philadelphia...

Prof Hervé Dombret, University Paris Diderot, Paris, France

Optimal use of tyrosine kinase inhibitors as a treatment for Philadelphia chromosome-positive acute lymphoblastic leukaemia ( Prof Hervé Dombret, University Paris Diderot, Paris, France )

Highlights from ICALL 2019

Prof Hervé Dombret - University Paris Diderot, Paris, France

Highlights from ICALL 2019 ( Prof Hervé Dombret - University Paris Diderot, Paris, France )

More from ecancer